Simplex Trading, LLC Mei Pharma, Inc. Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.54 - $2.74 $2,874 - $14,587	-5,324 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$2.33 - $3.37 $12,404 - $17,941	5,324 New	5,324 $14,000
Q1 2021 Apr 26, 2021	SELL	$2.73 - $4.5 $10,496 - $17,302	-3,845 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$2.6 - $3.32 $9,997 - $12,765	3,845 New	3,845 $10,000
Q3 2020 Oct 14, 2020	SELL	$2.46 - $4.27 $65,654 - $113,962	-26,689 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$1.45 - $4.3 $38,699 - $114,762	26,689 New	26,689 $110,000
Q2 2019 Jul 26, 2019	SELL	$2.45 - $3.32 $31,948 - $43,292	-13,040 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$2.52 - $3.24 $32,860 - $42,249	13,040 New	13,040 $0
Q4 2018 Jan 16, 2019	SELL	$1.92 - $4.1 $2,707 - $5,780	-1,410 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$3.39 - $4.61 $74,430 - $101,217	-21,956 Reduced 93.97%	1,410 $6,000
Q2 2018 Jul 30, 2018	BUY	$1.89 - $4.95 $44,161 - $115,661	23,366 New	23,366 $92,000
Q1 2018 Apr 26, 2018	SELL	$2.06 - $2.38 $4,332 - $5,005	-2,103 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$1.91 - $2.83 $4,584 - $6,792	-2,400 Reduced 53.3%	2,103 $4,000
Q3 2017 Oct 25, 2017	BUY	$2.44 - $2.91 $10,987 - $13,103	4,503	4,503 $12,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.